GHRS – gh research plc - ordinary shares (US:NASDAQ)
Stock Stats
News
GH Research Announces Publication of Phase 2b Results for Mebufotenin (GH001) in JAMA Psychiatry and Reports New Finding of Severity-Independent Efficacy in TRD
What Does GH Research PLC (GHRS)'s Clinical Progress Updates Say? [Yahoo! Finance]
GH Research FY25 Results: Strong Cash Position As GH001 Advances Toward Phase 3 [Seeking Alpha]
GH Research (GHRS) was given a new $34.00 price target by Guggenheim.
GH Research (GHRS) had its price target raised by Citizens Jmp from $39.00 to $42.00. They now have a "market outperform" rating on the stock.
Form 6-K GH Research PLC For: Mar 25
Form 6-K GH Research PLC For: Mar 16
Form S-8 GH Research PLC
Form 20-F GH Research PLC For: Dec 31
Form 6-K GH Research PLC For: Mar 05
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.